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Abstract
Purpose—Effective, consistent, and complication-free treat-
ment of cerebral bifurcation aneurysms remains elusive
despite a pressing need, with the majority of lesions present-
ing in such locations. Current treatment options focus either
on aneurysm coil retention, supported by a stent-like device
positioned in the parent vessel lumen, or intrasaccular
devices that disrupt ﬂow within the aneurysm dome. A third
alternative, i.e., the use of conventional (intraluminal) ﬂow-
diverters to treat such bifurcation aneurysms raises the
problem that at least one daughter vessel needs to be jailed in
such a deployment. The eCLIPs is a stent-like device that
offers the possibility of ﬂow-diversion at the aneurysm neck,
without the drawbacks of daughter vessel occlusion or those
of intrasaccular deployment.
Methods—In this study the eCLIPs device was virtually
deployed in ﬁve cerebral bifurcation aneurysms and com-
pared with a conventional tubular ﬂow-diverter device.
Computational ﬂuid dynamics (CFD) simulations of the
aneurysm haemodynamic environment pre- and post-im-
plantation were conducted, and focussed on metrics associ-
ated with successful aneurysm occlusion. Absolute and
relative reductions in aneurysm inﬂow rate (Q) and time-
averaged wall shear stress (TAWSS) were recorded.
Results—The eCLIPs device was found to perform in a
similar qualitative fashion to tubular ﬂow-diverters, with
overall reduction of metrics being somewhat more modest
however, when compared to such devices. Aneurysm inﬂow
reduction and TAWSS reduction were typically 10–20%
lower for the eCLIPs, when compared to a generic ﬂow
diverter (FDBRAIDED) similar to devices currently in clinical
use. The eCLIPs was less effective at diffusing inﬂow jets and
at reducing the overall velocity of the ﬂow, when compared
to these devices. This result is likely due to the larger device
pore size in the eCLIPs. Notably, it was found that the
eCLIPs provided approximately equal resistance to ﬂow
entering and exiting the aneurysm, which was not true for the
FDBRAIDED device, where high-speed concentrations of
outﬂow were seen at the aneurysm neck along with local
TAWSS elevation. The clinical implications of such beha-
viour are not examined in detail here but could be signiﬁcant.
Conclusions—Our ﬁndings indicate that the eCLIPs device
acts as a ﬂow-diverter for bifurcation aneurysms, with
somewhat diminished occlusion properties comparing to
tubular ﬂow diverters but without the jailing and diminished
ﬂow evident in a daughter vessel associated with use of
conventional devices.
Keywords—Cerebral aneurysm, Bifurcation aneurysm, Med-
ical device, Flow-diverter, Stent.
INTRODUCTION
The majority of cerebral aneurysms are known to
occur at vessel bifurcations.2,6 Despite signiﬁcant
innovation in cerebral aneurysm treatment in the past
two decades, only a small number of dedicated devices
are available to speciﬁcally treat bifurcation aneur-
ysms. Even fewer options are available when more
challenging wide-necked aneurysms must be treated.
The majority of these devices act as supports to enable
aneurysm coiling, such as the pCONus and pCANvas
devices (Phenox, Bochum, Germany) and PulseRider
(Pulsar Vascular/CERENOVUS J&J, Irvine, CA,
USA), while a smaller number of devices act as
intrasaccular ﬂow disruptors like the WEB (Sequent
Medical/MicroVention Terumo, Aliso Viejo, CA,
USA), Luna/Artisse (Medtronic, Dublin, Ireland) and
the Medina (Medtronic/Covidien/eV3, Dublin, Ire-
land) devices.
There are well-documented positive outcomes from
sidewall aneurysms treated with conventional, tube-
like, braided ﬂow-diverter devices, including the SILK/
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SILK + (Balt Extrusion, Montmorency, France), Pi-
peline Embolization Device (PED) (Medtronic/Covi-
dien, Dublin, Ireland), Flow Re-direction Endoluminal
Device (FRED) (MicroVention Terumo, Aliso Viejo,
CA, USA) and Surpass (Stryker Neurovascular, Fre-
mont, CA, USA).5 The use of conventional ﬂow-di-
verters in bifurcation cases, however, remains
controversial due to the necessity of jailing a daughter
vessel with the low-porosity device mesh. A number of
studies have reported daughter vessel occlusion or
incomplete aneurysm obliteration with neck remnants
in such cases.1,9,15,26,31,32,37 Although vessel occlusion
is often asymptomatic, given sufﬁcient collateral ﬂow
in the Circle of Willis,1 the long term risks and
reduction in retreatment options have made such off-
label use of conventional ﬂow diverters in bifurcation
aneurysms a rarity.
All bifurcation-speciﬁc ﬂow-diverter devices cur-
rently in clinical use (WEB, Artisse and Medina) re-
quire the device to be inserted into the aneurysm dome.
As such, while these devices can cover a range of an-
eurysm sizes, their use is typically limited to aneurysms
where there is good compliance between the aneurysm
and device shape. Consequently the success of treat-
ment is highly dependent upon accurate 3D measure-
ments of the aneurysm geometry.25 Additionally,
reports in the literature point towards concerns over
compaction of intrasaccular ﬂow-diverter devices and
poor outcomes when deployed in partially thrombosed
lesions.3,4
The eCLIPs (Evasc Medical Systems Corp.) is a
stent-like device that can be deployed to cover the neck
region of a bifurcation aneurysm, reducing inﬂow,
while still allowing unfettered access to daughter ves-
sels and microcatheter access to the aneurysm dome
for adjunctive coil placement. The eCLIPs—shown in
Fig. 1—is a doubly-curved device with two distinct
sections: one section with a set of anchoring ribs (vis-
ible in the distal portion of the device shown in the
ﬁgure) which secure the device in a daughter vessel
lumen, and a second section with higher-density ribs
that cover the aneurysm neck, which are capable of
both retaining coils and diverting ﬂow. The device is
non-cylindrical, resulting in greater compression/ex-
pansion at the vessel wall and giving good apposition
over a range of vessel sizes. The porosity of the
eCLIPs, approximately 65% with a range of 58–77%,
is similar to that of a conventional ﬂow diverter.
Complete details of the eCLIPs design, delivery in vivo,
and corresponding antiplatelet regimen are available in
the literature.8,17,28
Use of the eCLIPs pre-clinically and clinically as a
coil-assist device is documented in the literature.8,17,28
In two clinical cases the device was used without
adjunctive coiling—acting exclusively as a ﬂow-di-
verter device.8 The successful isolation of the lesion in
these cases raises the possibility of using the eCLIPs as
a dedicated ﬂow-diverter in other aneurysm geome-
tries.
In this study the ﬂow-diverting eﬀect alone of the
eCLIPs is investigated to ascertain whether treatment
without coil placement would be eﬀective in ﬁve
bifurcation aneurysm cases. The eCLIPs is virtually
compared to a conventional ﬂow-diverter device de-
ployed, with both the absolute value and relative
reduction in aneurysm inﬂow and wall shear stress
considered as metrics of treatment success.
METHODOLOGY
Aneurysm Geometries and Virtual Deployment
Five cerebral bifurcation aneurysm geometries (re-
ferred to as a1, a2, a3, a4, a5) were selected for virtual
deployment and CFD simulation by the eVasc clinical
team. Selection criteria for the geometries included
appropriate aneurysm and vessel size to support
treatment with the current generation of eCLIPs device
FIGURE 1. The eCLIPs device (a) as packaged and deployed
via microcatheter and (b) in top and side view during
manufacture.
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(size range for daughter vessels 2.00–3.25 mm diame-
ter). The selected geometries consisted of two basilar
tip aneurysms (a1 and a4 in Fig. 2) and three internal
carotid terminus aneurysms (a2, a3 and a5 in Fig. 2)
with maximum aneurysm dome and neck diameters
varying from 4.2 to 13.4 mm and 3.3 to 6.4 mm
respectively.
For modelling purposes, the anchoring section of
the device, shown in the right-hand portion of Fig. 1b,
was ignored entirely as it was assumed to have no
contribution towards aneurysm inﬂow reduction. It
was also assumed that the anchoring portion is placed
in the narrower/harder to access of the two daughter
vessels, as per previous clinical use of the device.29
A simpliﬁed wireframe version of the device was
deployed initially. The spine of the wireframe device
was located across the aneurysm neck along a previ-
ously deﬁned deployment line (Step I). The fully ex-
panded wireframe device was then placed (Step II). All
extraneous device ribs (those not covering the aneur-
ysm neck in some way) were removed for computa-
tional eﬃciency. Each rib of the device was deformed
into the approximate deployed conﬁguration within
the vessel (Step III). No material properties were as-
signed to the device and the local variation in rib
stiﬀness due to cross-section or orientation was not
incorporated in the wireframe. Instead, each wireframe
rib was deformed with a pseudo-realistic condition of
locally minimising deformed curvature in each rib,
with the device spine remaining rigid. Each rib was
trimmed after initial contact with the vessel wall to
maximise computational eﬃciency. The wireframe de-
vice was then solidiﬁed to create ribs and a central
spine of the same dimensions as the original device
(Step IV). This procedure was used to deploy the same
sized device in each of the ﬁve aneurysm geometries as
shown in Fig. 2. Note that in large aneurysms with an
amorphous neck (such as a1) the device can expand to
its full equilibrium diameter and leave a gap between
the device and vessel/aneurysm wall. In these cases the
eCLIPs remains anchored in the substantially smaller
daughter vessels.
Mesh Independence
Case a2 was selected for a mesh independence study
due to the relatively large ﬂow velocity magnitude and
gradient present in the aneurysm dome (identiﬁed in
previous computations). The geometry with and
without the eCLIPs device was meshed in CFD-Vis-
CART (ESI Group) with a projected single domain
unstructured mesh, an omnitree cartesian tree type and
three near-wall cartesian layers to give a smooth and
well-resolved boundary deﬁnition. This resulted in
initial meshes of 298,000 and 85,000 cells respectively
with and without the device deployed. The meshes
were incrementally reﬁned to give an approximate
doubling of the element count, resulting in maximum
mesh sizes of 24,300,000 and 14,100,000 cells respec-
tively with seven levels of reﬁnement.
For this test, steady state CFD computations were
performed assuming a constant blood ﬂow rate typical
of the ICA (230 mL/min) and a radially symmetric,
parabolic inlet velocity distribution. Blood was mod-
elled with constant density and viscosity of 1000 kg/m3
and 0.004 Pa s respectively, resulting in a Reynolds
number of 392 for this case. A plane was deﬁned just
within the aneurysm dome through which the aneur-
ysm inﬂow was measured. The aneurysm dome surface
was also isolated to measure WSS.
The reduction in aneurysm inﬂow due to the eCLIPs
device at each level of mesh reﬁnement was calculated
and the expected convergence behaviour toward a
ﬁxed reduction with increased mesh reﬁnement was
conﬁrmed. A mesh density greater than 5000 cells/mm3
was sufﬁcient to capture the inﬂow reduction with less
than 1% uncertainty. This ﬁnding is consistent with
previous studies and devices.21,23 The corresponding
reduction in mean and maximum wall shear stress
FIGURE 2. Deployed device configurations for each
aneurysm geometry in Basilar tip (a1, a4) and Internal
Carotid terminus (a2, a3, a5) locations. Aneurysm domes are
partially removed for device inspection.
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(WSS) with increasing mesh ﬁneness was also consid-
ered. In this case a level of mesh reﬁnement greater
than 5000 cells/mm3 was sufﬁcient for mesh indepen-
dence below 2%.
Overall a mesh ﬁneness of at least 5000 cells/mm3
was chosen to provide sufﬁcient conﬁdence regarding
mesh independence (1% on ﬂow, 2% on shear stress)
for all further computations.
CFD Setup
Each aneurysm case with the eCLIPs device deployed
was meshed to the previously deﬁned level of mesh
independence in CFD-VisCART (ESI Group), with the
same meshing setup as for the mesh independence tests.
Transient cardiac ﬂow proﬁles corresponding to the
ICAandBAwere taken froma 1Dmodel of the vascular
network and scaled to achieve ﬂow rates of 230 and
120 mL/min for the internal carotid and basilar arteries
respectively.27 A constant heart rate of 75 BPM was
assumed. Inlet velocity proﬁles were applied in a radially
symmetric parabola consistent with Poiseuille ﬂow, gi-
ven the relatively low Womersley number (< 3). Con-
stant pressure conditions were applied to all outlets with
no substantial differences seen in relative proportions of
outﬂow in each vessel when compared to in vivo obser-
vations in the literature.12,30 Vessel walls and the eCLIPs
device were assumed rigid.24
Blood was modelled as an incompressible Newto-
nian ﬂuid with a density of 1000 kg/m3 and a constant
dynamic viscosity of 0.004 Pa s. The governing un-
steady three-dimensional Navier–Stokes equations
were solved using the ﬁnite volume approach in CFD-
ACE + (ESI Group) employing a central differencing
scheme (second order) for spatial interpolation and a
Crank–Nicholson scheme (second order) for time
marching. SIMPLE-Consistent (SIMPLEC) pressure
correction was used in addition to an algebraic multi-
grid for convergence acceleration.20,34,35 We have
conﬁrmed through sensitivity analysis that a constant
time step of 0.001 s was sufﬁcient and we used a con-
vergence criterion of ﬁve orders of magnitude residual
reduction or an absolute residual reduction to
1 9 108 to assert iterative convergence of all variables
within each time step. Three full cardiac cycles were
simulated (2.4 s real time) with results reported for the
third cycle, to reduce transient effects. Mean Reynolds
numbers in the range of 274 to 392 were observed
across the ﬁve geometries, with an instantaneous peak
of 980, which supported the assertion for the laminar
nature of the ﬂow.10,14 Small Womersley numbers
(1.68–2.72) also conﬁrmed that little departure of the
velocity proﬁle from the Poiseuille case occurred.11,36
Computations were run on 32–64 cores with 32–64 GB
of RAM, depending on mesh size. Convergence was
typically seen in fewer than 50 iterations per timestep
and with a total solution time around 72–96 h.
Post-processing
A plane was prescribed at each aneurysm neck
through which inﬂow was measured. In the same spirit,
the aneurysm dome was isolated from the parent vas-
culature for WSS computations. Post-processing was
conducted in CFD-VIEW (ESI Group) and Matlab
(Mathworks) yielding a number of ﬂow metrics
including aneurysm inﬂow (cycle averaged and cycle
range), absolute intrasaccular velocity distributions,
and both spatial mean and maximum TAWSS (Time-
Averaged WSS). All time-averaged metrics were cal-
culated from the ﬂow distribution taken at 0.02 s
intervals (40 sample points per cardiac cycle).
Reductions in these metrics (Inﬂow, velocities,
TAWSSmean and TAWSSmax) are considered proxies
to successful aneurysm treatment.7,10,13,16,33 Reduced
inﬂow and lowered mean WSS are linked with
thrombus initiation in the aneurysm dome, similarly a
reduction in peak WSS is linked to reduced ﬂow jetting
and a reduction in rupture risk.18 However, the
TAWSSmax metric can be misleading in the absence of
a visualization of the shear stress distribution as the
location of the peak WSS may change signiﬁcantly
after device deployment. An additional metric was
calculated to capture the fraction of the aneurysm
dome under shear stress conditions conducive to
thrombosis initiation (a shear rate < 100 s1 or
WSS < 0.04 Pa s).19 This was quantiﬁed as the per-
centage area of the aneurysm dome under such con-
ditions with and without a device deployed.
Positioning Sensitivity Study
In order to quantify the eﬀect of positioning
uncertainty and variability on device performance,
three further computations were conducted for Case
a2. Speciﬁcally, the eCLIPs device was re-deployed in
(1) the original position; (2) a ‘‘Reversed’’ conﬁgura-
tion with the device anchored in the opposite daughter
vessel; (3) a ‘‘Plus 15 Deg.’’ conﬁguration with the
original device rotated about its longitudinal axis by
15 and (4) a ‘‘Minus 15 Deg.’’ conﬁguration with the
original device rotated 15 degrees in the opposite
direction. The same ﬂow and shear stress metrics were
computed for the three additional positions of the
device in Case a2.
Conventional Flow-Diverter Devices
The performance of the eCLIPs device was com-
pared to a generic woven ﬂow-diverter device (labelled
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as FDBRAIDED), similar to the SILK/SILK+ or Pi-
peline Embolization Device (PED). This device has a
porosity of ~ 70% and was created in length and
diameter combinations to mimic commercially avail-
able devices. The size of conventional device deployed
in each aneurysm case is summarised in Table 1.
Deployment and CFD modelling of these devices dis-
cussed in this paper were conducted previously with an
identical meshing setup, boundary conditions and de-
vice sizing according to manufacturers’ recommenda-
tions. Details of these computations are referred to
here for brevity and are available in the literature.22
RESULTS
The cycle-averaged reductions in aneurysm Inﬂow,
TAWSSmean and TAWSSmax due to the deployment
of each device are plotted in Fig. 3 as both columns
and coloured markers. The range of reductions seen
across the cardiac cycle is indicated in dashed error
bars for each column. In some geometries the con-
ventional FDBRAIDED device could be deployed in ei-
ther daughter vessel under manufacturer
recommendations and comparisons with both scenar-
ios are shown. The plots on the right-hand side of
Fig. 3 show a considerable spread of reductions about
the mean and relatively large standard deviations for
both devices, possibly excessively inﬂuenced by outliers
in the low sample size. Across all three plots the lowest
reductions seen correspond to Case G. Due to the low
number of samples no tests for Normality, such as
Shapiro-Wilks, could be performed. Consequently, the
deviation of the data from Normal is unknown.
Across the ﬁve cases the eCLIPs device produces a
relatively uniform and consistent reduction in aneur-
ysm inﬂow of approximately 30–40%, perhaps due to
the consistent size of the implanted device. The per-
formance of the FDBRAIDED on the other hand ap-
pears superior but more variable with inﬂow
reductions between 30 and 60%, and a larger standard
deviation in Fig. 3a. The reduction in mean TAWSS
(TAWSSmean) is far more variable for both devices. In
four treatment scenarios the FDBRAIDED produces
substantial reductions in TAWSSmean of around
80%, while the eCLIPs results in a reduction of around
60–70% in the same cases. This is reinforced by the
larger standard deviation for both devices seen in
Fig. 3b. A similar pattern emerges in the plot of
reduction in peak TAWSS (TAWSSmax) shown in
Fig. 3c with reductions in all cases, bar Case a3, of
around 80% due to the FDBRAIDED and 60–70% due
to the eCLIPs. Across all three plots of Fig. 3 Case a3
stands out with both devices performing poorly and
reducing both Inﬂow and TAWSSmean by around
30%.
TABLE 1. Size of conventional flow diverter device and
eCLIPs device implanted into each aneurysm geometry
Aneurysm Conventional device (FDBRAIDED) size eCLIPs size
a1 3 9 25 mm 3.25 mm
a2 4 9 20 mm 3.25 mm
a3 4 9 20 mm 3.25 mm
a4 3 9 20 mm 3.25 mm
a5 3.5 9 20 mm 3.25 mm
FIGURE 3. Reductions in inflow (a) and both mean (b) and
maximum (c) TAWSS across the five aneurysm geometries
due to the eCLIPs device and a conventional flow-diverter
(FDBRAIDED). Columns and coloured markers both indicate
cycle average, dashed error bars show cycle range. Solid
black markers and solid error bars indicate mean and
standard deviation of each distribution.
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The corresponding area of the aneurysm dome with
WSS magnitude that is low enough to initiate throm-
bosis is summarised in Fig. 4 for each device. In all
combinations bar one (the FDBRAIDED deployed in the
right-hand vessel of Case a3) the presence of a device
increases the area of the aneurysm dome under this
preferential condition. Substantial variation in the
aneurysm area fraction is seen across the cases and
devices—ranging from around 1 to 80%. With the
exception of Case a4 the FDBRAIDED device increases
this area to at least 30% across the cases regardless of
deployment position. The eCLIPs device shows a lar-
ger range of aneurysm area fraction under preferential
shear conditions—around 20–80% when case a4 is
again excluded.
It should be noted that this area-based metric does
not capture the risks associated with jets of ﬂow on the
aneurysm wall, which may only exist on a small area of
the dome but have been linked with poor treatment
outcomes. Similarly, the reduction in TAWSSmax may
be misleading as the location at which the maximum
TAWSS occurs is not considered; placement of a de-
vice could reduce a ﬂow jet and lower TAWSSmax, but
the resulting jet and TAWSSmax could impact a more
critical area of the aneurysm, such as a vulnerable bleb.
Detailed visual inspection of aneurysm ﬂow and shear
stress patterns is conducted in the next section.
Across the geometries daughter vessel outﬂow
fractions were also compared for both the eCLIPs and
conventional device. In both cases there was very little
departure (< 5%) in outﬂow fraction compared to the
No Device case suggesting that, in the ﬁrst instance,
neither device presents a daughter vessel occlusion risk.
However, without incorporating biochemical models
to capture device endothelialization the actual occlu-
sion of the daughter vessel cannot be predicted.
Figures 5 and 6 show lines tangent to the instanta-
neous velocity vector, at mean ﬂow rate, colour-coded
for magnitude, and WSS distributions respectively at
the same time step with and without eCLIPs or
FDBRAIDED devices.
Case a1 In the a1 case, broadly similar performance
is seen between the two device types and the two
deployment conﬁgurations of the FDBRAIDED device:
inﬂow and WSS metrics are reduced by 40–50% and
70–80% respectively. The action of each device on the
aneurysm ﬂow pattern in a1 does vary: the
conventional device diffuses the ﬂow into a broader,
less coherent jet that results in fewer areas of elevated
WSS in the aneurysm dome when compared to the
eCLIPs device. Overall the large size of the aneurysm
dome in this case diffuses the relatively large inﬂow
(even after device placement this averages ~ 60 mL/
min) to create a shear stress environment conducive to
thrombosis—reinforced by Fig. 4. The elimination of a
jet-induced high WSS region by all devices is likely to
address many of the clinical concerns for this large
aneurysm.
Case a2 Figures 5 and 6 summarise the same
combination of velocity and WSS distributions for
Case a2. In this case the eCLIPs device underperforms
the FDBRAIDED by around 20–30% when comparing
reductions in key metrics. Across the velocity plots, it
is clear that the fundamental aneurysm ﬂow pattern is
relatively unchanged by either device placement: ﬂow
enters at the back of the aneurysm and exits at the
front, causing two peaks in WSS either side of the main
aneurysm dome. These WSS peaks are reduced in
severity and extent by both devices but more so by the
smaller-pored FDBRAIDED, which reduces the entire
aneurysm dome to a WSS below 2.5 Pa at mean ﬂow.
This is reﬂected in the plot of Fig. 4 where the
conventional device places almost 60% of the
aneurysm dome in a favourable shear stress
environment, compared to the ~ 20% (approximately
double the preferential area with no device present)
achieved by the eCLIPs. In this case the relatively low
reduction in aneurysm inﬂow for the eCLIPs device
(32.2%) also translates into a high absolute inﬂow
value after device placement, averaging ~ 70 mL/
min—the highest post-device placement seen in this
study. Together these factors would anecdotally point
towards a reduced potential for aneurysm occlusion
with the eCLIPs in this geometry.
Case a3 Figures 5 and 6 summarises the equivalent
distributions and metric reductions for Case a3. As was
FIGURE 4. Aneurysm area below critical WSS for thrombus
initiation displayed by case and device.
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noted in Fig. 3, Case a3 shows markedly lower
reductions in the three metrics considered for both
devices (typically 30–40%), when compared to the
other four aneurysm cases. However, these reductions
should be considered alongside the relatively low
absolute aneurysm inﬂow with or without a device,
visible in the small number of ﬂow lines entering the
aneurysm dome. As such the aneurysm inﬂow rates
seen after deployment of either device are the lowest
across all ﬁve cases (~ 25 mL/min), which is likely low
enough to encourage thrombosis. This point is
reinforced by the more positive performance of Case
a3 when considering the area of the aneurysm under
WSS favourable for thrombosis (Fig. 4), but the same
plot also shows the unusual result of the FDBRAIDED
device actually decreasing this area. This effect results
from the FDBRAIDED diffusing the concentrated ﬂow
entering the aneurysm into a slower moving core that
then sweeps a larger fraction of the aneurysm dome,
when compared to the more extreme high and low
WSS areas visible in No Device and eCLIPs
conﬁgurations.
The plot of TAWSSmax reduction in Fig. 3 is also
somewhat misleading showing a greater reduction for
the eCLIPs device when the FDBRAIDED actually
FIGURE 5. Velocity magnitude plots at mean flowrate for each aneurysm case a1–5 with and without a device deployed for both
the eCLIPs and FDBRAIDED. Where the FDBRAIDED has been deployed in either the left or right daughter vessel this is indicated.
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eliminates the WSS peak located at the aneurysm’s
minor lobe. The poor performance of the conventional
device captured in the graph has resulted from the
higher WSS zone at the extreme left of the aneurysm
dome (adjacent to the Anterior Communicating Ar-
tery) where ﬂow leaving the aneurysm dome is con-
centrated.
Given the (pro-thrombotic) low aneurysm inﬂow
rate, even in the absence of a device, the clinical con-
cerns with this case are likely to focus on the high-
WSS-inducing ﬂow jet. Both the eCLIPs and
FDBRAIDED reduce the impact of this jet but the more
effective jet reduction of the conventional device is
offset by a corresponding increase in impingement of
ﬂow leaving the aneurysm. Such a concentrated an-
eurysm outﬂow region may correlate with the persis-
tent neck remnants seen in the literature.1,26,32 There is
also likely a secondary (positive) effect of the eCLIPs
fully covering the aneurysm neck compared to the
parent vessel placement of the FDBRAIDED in that the
eCLIPs presents a platform for endothelialization that
spans the aneurysm neck entirely.
Case a4 The velocity and WSS distributions for Case
a4 are also shown in Figs. 5 and 6. In this case all
devices reduce the violent ﬂow pattern within the
FIGURE 6. Wall shear stress (WSS) magnitude plots at mean flowrate for each aneurysm case a1–5 with and without a device
deployed for both the eCLIPs and FDBRAIDED. Where the FDBRAIDED has been deployed in either the left or right daughter vessel this
is indicated.
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aneurysm dome and in particular the eCLIPs device
and the conventional device deployed in the right-hand
daughter vessel perform very similarly. Although the
corresponding reductions in ﬂow and shear stress
metrics are similar between these two conﬁgurations,
the FDBRAIDED device again diffuses the ﬂow jet
entering the aneurysm more by reducing the velocity of
the ﬂow more substantially. This translates into a more
effective reduction in shear stress peaks in the
aneurysm dome with the FDBRAIDED (right), which
are still present with the eCLIPs device, but as with the
previous case the area of peak WSS shifts to where
ﬂow exits the aneurysm in the FDBRAIDED case.
Performance with the FDBRAIDED device deployed
in the opposite daughter vessel (left) is substantially
improved. This better performance results from dis-
rupting the fundamental ﬂow pattern of the aneurysm
dome, where ﬂow now enters more centrally, and by
the more tightly packed device struts restricting ﬂow
more—both effects documented in previous publica-
tions.22 This superior performance of the FDBRAIDED
deployed in the left vessel is very visible in Fig. 4 where
all other device conﬁgurations only result in pro-
thrombotic shear stress values in less than 5% of the
aneurysm dome area.
The relatively high absolute inﬂow rates (~ 40–
60 mL/min) in this small aneurysm with any device
deployed, combined with the small fraction of aneur-
ysm dome under pro-thrombotic shear stress (with the
exception of the FDBRAIDED left conﬁguration) point
towards low potential for aneurysm occlusion. It
should also be noted that the superior performance of
the conventional device results exclusively from the
subtle choice of deployment location.
Case a5 Finally, the ﬂow distributions for Case a5
are shown in Figs. 5 and 6. For both the eCLIPs and
FDBRAIDED the presence of the device retains the ‘‘no
device’’ ﬂow pattern but reduces the speed and violence
of the aneurysm ﬂow. The shear stress patterns are
correspondingly reduced in magnitude after device
deployment but in both cases the fundamental WSS
pattern of high and low locations remains. The eCLIPs
underperforms the conventional device in inﬂow
reduction by a substantial margin (~ 20%), which
leads to similar differences in the reduction of mean
TAWSS. As in previous cases this is visible as a more
diffuse, low-velocity jet of ﬂow entering the aneurysm
in the conventional device case. Both devices also
dramatically increase the fraction of aneurysm area
under pro-thrombotic shear stress (Fig. 4) but again
the FDBRAIDED does so to a greater effect.
As with previous cases a less dramatic diﬀerence in
TAWSSmax reduction is seen between the devices
despite more eﬀective jet elimination by the
FDBRAIDED, and as previously, a corresponding in-
crease in neck WSS is caused by exiting ﬂow, which
counters this reduction for the conventional device.
Large diﬀerences in absolute aneurysm inﬂow rate
(~ 30 vs. ~ 45 mL/min) between the eCLIPs and
FDBRAIDED devices combined with more effective jet
elimination and low shear stress promotion do point
towards the FDBRAIDED being the more effective
treatment option for this case. However, the perfor-
mance seen for the eCLIPs may also be sufﬁcient for
thrombosis and occlusion.
Aneurysm Velocity Histograms
Further detail of the ﬂow within the aneurysm dome
may be captured by considering the histogram of
velocity magnitude within the aneurysm dome (J.
Cebral 2018, personal communication), as shown for
Case a2 in Fig. 7. Both the velocity histogram shape
and mean value give an indication of the likelihood of
thrombosis in the aneurysm dome—where
stable thrombus is likely to be encouraged by a uni-
form low velocity throughout the aneurysm dome. The
introduction of either the eCLIPs or FDBRAIDED de-
vice in Case a2 reduces the mean dome velocity by 47
and 73%, respectively, while 90% of the ﬂow in the
aneurysm dome is below 0.310, 0.014, 0.08 ms1 with
No Device, the eCLIPs and FDBRAIDED respectively.
Equally the same ﬂow distributions can be charac-
terised by the fraction of the aneurysm dome with a
FIGURE 7. Aneurysm dome velocity histograms for Case a2
with and without devices deployed. Spatial means are
indicated in corresponding coloured text.
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velocity below 0.01 ms1 as 7.0, 15 and 54% respec-
tively for the No Device, eCLIPs and FDBRAIDED
conﬁgurations. These results broadly align with the
inﬂow reduction seen for Case a2 where the eCLIPs
produced an inﬂow reduction of approximately half
that of the FDBRAIDED.
Positioning Study Results
As shown in Fig. 8, the position of the eCLIPs de-
vice in a2 case does not appear to substantially affect
the reductions in the three key metrics considered, with
the exception of an almost 20% greater reduction in
peak TAWSS when the device is reversed. The change
in device position appears to mainly alter the location
and number of high WSS areas in the aneurysm dome:
two regions of approximately equal size and magnitude
are present in the ‘‘eCLIPs’’ and ‘‘Minus 15 Deg.’’
conﬁgurations (visible on the front and back of the
main aneurysm lobe) while a single region dominates
in the ‘‘Reversed’’ and ‘‘Plus 15 Deg.’’ cases (a high
WSS area on the front and back faces of the main
aneurysm lobe). The superior TAWSSmax reduction
performance of the ‘‘Reversed’’ device appears to
correlate with the elimination of the high WSS region
on the back face of the aneurysm dome. The ‘‘Rev-
ersed’’ conﬁguration also produces a unique ﬂow pat-
tern: in all other conﬁgurations ﬂow enters and exits
the aneurysm centrally at the back and front respec-
tively, whereas in the ‘‘Reversed’’ conﬁguration ﬂow
enters on the left of the aneurysm dome towards the
back face and exits on the right-hand side.
Similar results are seen for the area of aneurysm
dome below a critical WSS. All positions of the device
perform relatively poorly on this metric (20–30% area
compared to > 50% for the FDBRAIDED) and again a
slightly improved performance is seen in the reversed
conﬁguration where more of the aneurysm rear wall
experiences lower TAWSS. Generally, the ﬂow pat-
terns and metric reductions appear relatively insensi-
tive to variation in the positioning of the eCLIPs
device.
STUDY LIMITATIONS
Due to the speculative and computational modelling
approach taken, this study has a necessary number of
limitations. Primarily, only the instant after device
implantation has been modelled—no capturing of the
aneurysm thrombosis and device endothelialization
that are necessary for successful treatment have been
considered, only surrogate measures of these processes.
Inferred boundary conditions of ﬂow (population-av-
eraged ﬂowrate and parabolic proﬁle) and outlet
pressure (ﬁxed) were implemented due to the lack of
patient-speciﬁc data for the aneurysm cases concerned.
The inﬂuence of these factors on the conclusions drawn
in the study is considered small, given the like-for-like
comparison with the known technology of a conven-
tional ﬂow diverter device.
CONCLUSIONS
Overall the eCLIPs device exhibits a small but
measurable performance reduction, when compared to
a conventional ﬂow-diverter (FDBRAIDED) deployed in
the same ﬁve aneurysm cases. The eCLIPs typically
reduced aneurysm inﬂow by around 10–20% less with
similar reductions seen in mean shear stress. Small
sample sizes mean it is not possible to interrogate the
signiﬁcance of this result.
On the other hand, the eCLIPs device consistently
produced a uniform reduction in aneurysm inﬂow
of ~ 30–40% under a wide range of aneurysm inﬂow
FIGURE 8. Case a2 positioning study results showing
velocity and WSS distributions at mean flow rate with and
without the eCLIPs and FDBRAIDED devices deployed.
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rates prior to implantation (~ 40–115 mL/min). By
contrast the FDBRAIDED device produced ﬂow reduc-
tions in the range of ~ 30–60%, where the consistency
of the ﬂow-diverter appears more dependent on de-
ployed position and device sizing.
Compared to the conventional device the eCLIPs
was less eﬀective at diﬀusing jets of ﬂow entering an-
eurysms and lowering the ﬂow velocity. Consequently,
local peaks in shear stress were less eﬀectively reduced
by the eCLIPs. This is likely due to the signiﬁcantly
larger eﬀective pore size of the eCLIPs device and the
lower pore density. This eﬀect of pore size does not
appear to adversely aﬀect endothelialization, as pre-
vious pre-clinical studies of the eCLIPs have shown
complete incorporation of the device 30–90 days after
implantation.
The eCLIPs provided approximately equal resis-
tance to ﬂow entering and exiting the aneurysm
dome—covering the entire neck—unlike the
FDBRAIDED, which primarily restricted ﬂow entering
the aneurysm. In the case of the FDBRAIDED this led to
high-speed ﬂow exiting the aneurysm in a very con-
centrated location in some cases, with a corresponding
increase in local shear stress. This behaviour may
correlate with the neck remnants recorded in the lit-
erature following FD treatment of bifurcation aneur-
ysms.
These results conﬁrm that the eCLIPs device can
indeed act as a ﬂow-diverter. The eCLIPs does not
match the performance of conventional ﬂow-diverters
but it is unclear what degree of ﬂow-diversion is suf-
ﬁcient for eﬀective aneurysm isolation.
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